Lucy Scientific Discovery Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Lucy Scientific Discovery Inc. (NASDAQ: LSDI) is an early-stage psychotropics contract manufacturing company engaged in the research, development, manufacturing, and commercialization of psychedelic and psychotropic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products; it also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. Founded in 2017 and headquartered in Victoria, British Columbia, Canada, Lucy Scientific operates primarily in the healthcare sector, focusing on drug manufacturers specializing in psychotropic medicines for mental health and addiction treatments, with a Controlled Drugs and Substances Dealer's License from Health Canada authorizing the handling of pharmaceutical-grade APIs for controlled substances. In 2023, the company acquired the intellectual property and brand assets of High Times Holding Corp., including rights to High Times, 420.com, and Cannabis Cup brands, for 19.9% of its outstanding stock plus EBITDA-based payments over five years, anticipating over $10 million in additional revenue and $5 million in EBITDA growth; it also announced the acquisition of BlueSky Wellness Inc. and its portfolio of wellness brands such as Keoni and Blush Wellness, though the deal was later cancelled. Recent initiatives include the launch of the Twilight sleep aid product containing amanita muscaria and reishi mushrooms, as well as a partnership with Wesana Health Holdings Inc. to develop SANA-013, a CBD and psilocybin-based drug for migraines, cluster headaches, and major depressive disorder.
Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Why Is Lucy Scientific Discovery (LSDI) Stock Up 227% Today?
Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health
Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create ‘Golden Opportunity' for Growth, Success
Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth
Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition
Lucy Scientific Discovery Inc. Announces Acquisition of BlueSky Wellness Inc. in All-Stock Transaction
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market
Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction
Lucy Scientific Discovery Inc. Unveils New Sleep Aid Product: Twilight by Lucy
IPO Round Up of First Half of 2023
Best Penny Stocks Today? 4 With Big News To Watch This Week
LSDI Stock Alert: Lucy Scientific Soars on Product Launch Update
Lincoln Private Market Index Grows Modestly in Q1 2023 as a Result of Resilient Private Company Performance
Lucy stock is up 15% on Tuesday: what happened?
WestPark Capital Announces Closing of $7.5 Million IPO for Lucy Scientific Discovery Inc. (NASDAQ:LSDI)
Lincoln Private Market Index Grows Modestly in Q4 2022 Amid Public Market Volatility
Lincoln Private Market Index Modestly Increases, but Private Markets Are Beginning to Cool Off